Galux Companies
Developer of molecular design technology designed to develop novel drugs against attractive targets.Employees: 23Occupation: Founder & Chief Executive OfficerGalux Company Profile: Valuation, Funding & Investors | PitchBookpitchbook.com/profiles/company/497791-81
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Seoul, South Korea
Founded Date:
2020
Register and Claim Ownership